The Chilean pharmaceutical market is recognized as one of the most stable and transparent in Latin America. As a leading Generic Medicines Supplier serving Chile, Jiangxi Serum Pharma Industries Co., Ltd. understands the unique dynamics of this market, which is characterized by a high demand for cost-effective, high-quality bioequivalent medications. Chile’s regulatory body, the Instituto de Salud Pública (ISP), maintains rigorous standards, ensuring that all generic drugs meeting the criteria for "Bioequivalence" provide the same therapeutic effect as their innovator counterparts.
Chile's pharmaceutical market is projected to grow at a CAGR of 5.8%, driven by an aging population and government initiatives like the Ley de Fármacos. For international suppliers, navigating the CENABAST (Central de Abastecimiento del Sistema Nacional de Servicios de Salud) procurement system is critical for large-scale impact.
Globally, generic medicines account for over 80% of prescription volume, saving healthcare systems hundreds of billions of dollars annually. In the context of Chile, the push for "Universal Access to Medicines" has made China-based manufacturers essential partners. Our role as a global supplier is to bridge the gap between world-class manufacturing efficiency and Chile’s local clinical needs, ensuring that from Arica to Punta Arenas, high-quality treatment remains affordable.
Entering the Chilean market requires more than just a product; it requires a commitment to E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness). Jiangxi Serum Pharma provides comprehensive dossier support for ISP registration, including:
Supporting the Sistema Nacional de Servicios de Salud (SNSS) with high-volume antibiotic injections and IV fluids, essential for critical care across Chile's regional hospital network.
Providing white-label and branded generics for major Chilean retail chains, focusing on chronic disease management like hypothyroidism and infection control.
Supplying specific treatments for premature ejaculation and hormonal therapies, catering to the growing private healthcare sector in Santiago and Concepción.
Implementing real-time tracking and environment monitoring for all shipments to Chile, ensuring transparency from the factory floor to the Chilean distributor.
Transitioning to green-chemistry and advanced bio-fermentation for raw material production to reduce environmental impact and improve API purity.
Introducing a wider range of biosimilars and vaccines specifically tailored to the epidemiological profile of the Latin American region.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, medical consumables, with high quality and affordable prices. Serum Pharma will continuously monitor the development of the cutting-edge markets. Currently, we have already cooperated with our partners on the customization of Pre-Mix, Co-Crystallization and Bio-Fermentation products service.
